201
|
Chiumello D, Caironi P, Grasso S, Mascia L, Terragni PP, Rossi M. A year in review in Minerva Anestesiologica 2010. Critical care. Experimental and clinical studies. Minerva Anestesiol 2011; 77:101-115. [PMID: 21273973] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 05/30/2023]
|
202
|
Current world literature. Curr Opin Endocrinol Diabetes Obes 2010; 17:568-80. [PMID: 21030841 DOI: 10.1097/med.0b013e328341311d] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
203
|
Monzavi R, Kim M, Austin J, Vedin A, Franklin S. Meeting highlights: Endocrine Society, San Diego, California, June 19-22, 2010. PEDIATRIC ENDOCRINOLOGY REVIEWS : PER 2010; 8:114-122. [PMID: 21174899] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 05/30/2023]
|
204
|
Abstract
Disrupted or aberrant endocrine signaling has profound effects on the health of both children and adults. This issue focuses attention on endocrine signaling mediated by G protein-coupled receptor and receptor tyrosine kinase pathways involved in endocrine signaling, especially those critical in child development and health. Research in this issue highlights gender-specific differences in glucocorticoid signaling, which have implications for gender-specific treatment of inflammatory diseases.
Collapse
|
205
|
Hagiwara S. [Working despite having diseases: Endocrine system diseases and metabolic diseases]. RINSHO BYORI. THE JAPANESE JOURNAL OF CLINICAL PATHOLOGY 2010; Suppl 146:83-95. [PMID: 21584990] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 05/30/2023]
|
206
|
Feitosa ACR, Queiroz AM, Vianna AM, Schleu M. [Application of multidisciplinary educational program in high-risk pregnancies due to endocrine diseases]. REVISTA BRASILEIRA DE GINECOLOGIA E OBSTETRÍCIA 2010; 32:504-509. [PMID: 21271158] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/03/2010] [Accepted: 09/30/2010] [Indexed: 05/30/2023] Open
Abstract
PURPOSE to investigate the application of a multidisciplinary educational program to high-risk pregnancies due to endocrine diseases. METHODS we retrospectively evaluated the application of a multidisciplinary educational program to 185 pregnant women with endocrine diseases referred to a maternity specialized in high-risk pregnancy. All pregnant women received multidisciplinary prenatal care from a team consisting of endocrinologists, obstetricians, sonographers, nurses and dietitians. Oral and written information about healthy habits, diabetes care, use of artificial sweeteners and exercise during pregnancy was given to all patients at the first endocrine consultation. An individualized nutrition plan was prepared on the occasion of the first visit to the nutritionist. In bi-weekly and monthly endocrine and nutritional visits, respectively, information about healthy changes in lifestyle was emphasized and the weight was recorded. Adherence to physical activity and nutritional counseling was self-reported. We compared the weekly weight before and after the intervention, fetal weight at birth, rate of macrosomia and low birth weight, and frequency of cesarean delivery among the four categories of body mass index (BMI) before pregnancy (<18.5, from 18.5 to 24.9, from 25 to 29.9 and >30 kg/m²). RESULTS the main disease of referral was diabetes (84.9%). One third of the pregnant women (31.2%) were overweight and 42.5% were obese before pregnancy. Most women was first seen by the multidisciplinary team in the third trimester of pregnancy (64.1%) and 50.5% exceeded the recommended weight gain at first evaluation. Obese women exceeded the recommended weight gain in 62.5% of cases. After the intervention, the percentage of women who exceeded the recommended weekly weight gain was reduced in all categories of pre-pregnancy BMI, although a statistically significant difference was found only in the group with normal pre-pregnancy BMI (40.6 versus 21.9%, p = 0.03). At birth, average fetal weight was similar among the various BMI categories (p=0.277). Macrosomia was more frequent in women who were overweight and obese before pregnancy. Cesarean delivery was the most frequent route of delivery, regardless of pre-pregnancy BMI. CONCLUSIONS in high-risk pregnancies due to endocrine disorders, a multidisciplinary educational approach limits excessive weekly weight gain despite the advanced gestational age.
Collapse
|
207
|
Peteiro-González D, Martínez-Olmos MA, Peinó R, Prieto-Tenreiro AM, Villar-Taibo R, Andujar-Plata P, Guillín-Amarelle C. [Adult celiac disease: endocrinological and nutritional issues]. NUTR HOSP 2010; 25:860-863. [PMID: 21336447] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/29/2010] [Accepted: 04/17/2010] [Indexed: 05/30/2023] Open
Abstract
Celiac disease is an autoimmune enterophaty induced by the ingestion of gluten in genetically susceptible individuals. Although historically it was thought that it was an infrequent pediatric disease, now it is know that its prevalence is close to 1% in the general population. It is even higher between patients with some endocrine disorders and nutritional deficits. The use of antitransglutaminase and antiendomisium antibodies and the endoscopical duodenal biopsy are the cornerstones for its diagnosis. The introduction of a gluten-free diet will achieve the normalization of the intestinal mucosa. It will avoid the risk of long term complications and an it will achieve an improvement in quality of life. Medical and dietitian long term follow-up will be important to improve the compliance to the treatment.
Collapse
|
208
|
Wang XF. [Diagnosis and treatment of male testosterone deficiency]. ZHONGHUA NAN KE XUE = NATIONAL JOURNAL OF ANDROLOGY 2010; 16:291-294. [PMID: 20626153] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 05/29/2023]
Abstract
Testosterone, as the most important sex hormone of the male, plays a critical role in growth, development, reproduction, and maintenance of the functions of vital organs. Testosterone deficiency may lead to functional disorders in many organs or systems, which are collectively termed testosterone deficiency syndrome (TDS). TDS is a clinical and physiochemical syndrome resulted from ageing. It is recognized that the abnormally low level of testosterone is correlated with the male unhealthy status. As for the treatment of TDS, disputes exist over the necessity of testosterone supplement and the time to start the therapy, because the testosterone threshold that induces the clinical symptoms differs among different individuals and the symptoms are non-specific.
Collapse
|
209
|
Abstract
Patients with endocrinopathies frequently present to the operating room. Although many of these disorders are managed on a chronic basis, patients may have acute changes in the perioperative period that, if left unrecognized, can have a negative effect on perioperative morbidity and mortality. It is imperative that anesthesiologists understand the implications of the surgical stress response on hormonal flux. This article focuses on the 4 most commonly encountered endocrinopathies: diabetes mellitus, hyperthyroidism, hypothyroidism, and adrenal insufficiency. Specific challenges pertaining to patients with pheochromocytoma are also discussed.
Collapse
|
210
|
Perez P, Rowzee AM, Zheng C, Adriaansen J, Baum BJ. Salivary epithelial cells: an unassuming target site for gene therapeutics. Int J Biochem Cell Biol 2010; 42:773-7. [PMID: 20219693 DOI: 10.1016/j.biocel.2010.02.012] [Citation(s) in RCA: 28] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/09/2009] [Revised: 02/05/2010] [Accepted: 02/19/2010] [Indexed: 11/17/2022]
Abstract
Salivary glands are classical exocrine glands whose external secretions result in the production of saliva. However, in addition to the secretion of exocrine proteins, salivary epithelial cells are also capable of secreting proteins internally, into the bloodstream. This brief review examines the potential for using salivary epithelial cells as a target site for in situ gene transfer, with an ultimate goal of producing therapeutic proteins for treating both systemic and upper gastrointestinal tract disorders. The review discusses the protein secretory pathways reported to be present in salivary epithelial cells, the viral gene transfer vectors shown useful for transducing these cells, model transgenic secretory proteins examined, and some clinical conditions that might benefit from such salivary gland gene transfer.
Collapse
|
211
|
Michels AW, Eisenbarth GS. Immunologic endocrine disorders. J Allergy Clin Immunol 2010; 125:S226-37. [PMID: 20176260 PMCID: PMC2835296 DOI: 10.1016/j.jaci.2009.09.053] [Citation(s) in RCA: 68] [Impact Index Per Article: 4.9] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/18/2009] [Revised: 09/17/2009] [Accepted: 09/18/2009] [Indexed: 01/12/2023]
Abstract
Autoimmunity affects multiple glands in the endocrine system. Animal models and human studies highlight the importance of alleles in HLA-like molecules determining tissue-specific targeting that, with the loss of tolerance, leads to organ-specific autoimmunity. Disorders such as type 1A diabetes, Graves disease, Hashimoto thyroiditis, Addison disease, and many others result from autoimmune-mediated tissue destruction. Each of these disorders can be divided into stages beginning with genetic susceptibility, environmental triggers, active autoimmunity, and finally metabolic derangements with overt symptoms of disease. With an increased understanding of the immunogenetics and immunopathogenesis of endocrine autoimmune disorders, immunotherapies are becoming prevalent, especially in patients with type 1A diabetes. Immunotherapies are being used more in multiple subspecialty fields to halt disease progression. Although therapies for autoimmune disorders stop the progress of an immune response, immunomodulatory therapies for cancer and chronic infections can also provoke an unwanted immune response. As a result, there are now iatrogenic autoimmune disorders arising from the treatment of chronic viral infections and malignancies.
Collapse
|
212
|
Krawczuk-Rybak M. [Endocrine disorders in children after treatment for brain tumors]. Pediatr Endocrinol Diabetes Metab 2010; 16:114-118. [PMID: 20813089] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 05/29/2023]
Abstract
Endocrine dysfunction is one of the most common late effect of anticancer treatment. The kind and degree of the disorder depend on tumor location, therapy, especially on the dose of radiotherapy, different sensitivity of the hypothalamo-pituitary axes to irradiation, as well as on the time of treatment. The growth hormone secretion axis is the most vulnerable part, and growth disorders occure most frequently (after a total dose of >30 Gy); then, after a total dose of 50-60 Gy: gonadotropin, ACTH deficiency, and, rarely, TSH deficiency. Spinal irradiation leads to the height loss and disproportionate growth as well as dysfunction of gonads and thyroid gland. Chemotherapy (alkylating agents) deteriorates gonadal function. The recognition, good and early diagnosis and therapy are important to improve the quality of life of the survivors.
Collapse
|
213
|
Starzyk J, Pituch-Noworolska A, Pietrzyk JA, Urbanik A, Kroczka S, Drozdz R, Wójcik M. [Non-structural abnormalities of CNS function resulting in coincidence of endocrinopathies, epilepsy and psychoneurologic disorders in children and adolescents]. PRZEGLAD LEKARSKI 2010; 67:1127-1131. [PMID: 21442962] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 05/30/2023]
Abstract
BACKGROUND In the population of children and adolescents, epilepsy affects approximately 1% of cases, nonepileptic seizures are seen in approximately 3%, and endocrine disorders are several times more common. For this reason, coincidence of endocrine disorders and epilepsy and psychoneurologic disorders is frequent. Much less common are structural abnormalities (tumors, developmental abnormalities), and especially non-structural CNS abnormalities, resulting in coincidence of both disorders. There are no reports available in the literature that would address the problem. AIM OF THE STUDY 1) Assessment of the frequency of coincidental epilepsy and endocrine disorders in patients without structural CSN abnormalities treated as outpatients and inpatients of Department of Endocrinology University Children's Hospital of Krakow. 2) Presentation of diagnostic and therapeutic difficulties in these patients, and 3) An attempt at defining the common etiology of both disorders. MATERIAL AND METHODS On the basis of ICD code patients with coincidance of endocrine disorders, epilepsy and psychoneurologic disorders were selected from several thousands of children treated between 2000 and 2009 in Pediatric Endocrinology Department. The neurologic disorders were diagnosed and treated in Chair and Department of Children's and Adolescents Neurology or in another pediatric neurology center. RESULTS Various forms of epilepsy (symptomatic or idiopathic) and other psychoneurological disorders (disorders of behavior and emotions, obsession-compulsion syndromes, stereotypias, aggression, autoaggression, or hypothalamic obesity) coincident with one or more endocrine disorders, such as growth disorders, disorders of pubertal development, obesity, thyroid diseases, adrenal diseases, hyperprolactinemia, hypoparathyroidism and ion metabolism disorders were diagnosed in 49 patients. The group included: i) children after cranial irradiation and chemotherapy due to medulloblastoma (3 patients), oligodenroglioma (1 patient), ependymoma (1 patient), optic chiasm glioma (2 patients), suprasellar germinal tumor (1 patient), ii) children with Hashimoto encephalopathy (2 patients), iii) children with Prader-Willi syndrome (20 patients), with Klinefelter syndrome (10 patients), with Albright syndrome (9 patients). Of the 49 patients, a group of 6 children representative for individual disorders was selected. In those patients, the etiology of both endocrine disorders, epilepsy and neuropsychiatric disorders was suspected to be common, and the diagnosis was usually delayed. CONCLUSIONS 1. Cranial irradiation and chemotherapy, encephalopathy associated with Hashimoto disease and some of the syndromes with the chromosomal and genetic background are the causes of non-structural CNS abnormalities and coincidence of endocrinopathies, epilepsy and psychoneurologic disorders. 2. MR/CT CNS imaging should be performed in any case of central neurological disorders, disorders of behavior, epilepsy or seizures, but also in patients with delayed psycho-motor development, delayed or accelerated growth and pubertal development. All of the above-mentioned manifestations may be symptoms of structural CNS abnormalities and their early treatment determines the child's future. 3. Excluding structural CNS abnormalities allows for forming suspicions associated with diseases resulting in non-structural disorders of the CNS function, predisposing to coincidence of endocrine and neurological disorders. 4. In the diagnosis of Hashimoto's encephalopathy, a decisive factor is exclusion of structural, infectious, traumatic and metabolic causes, intoxications, epilepsy and presence of neuropsychiatric symptoms in patients with high level of against TPO antibodies. In cases of steroids resistance, a good therapeutic effect may be achieved by plasmapheresis, Rituximab therapy and progestagene inhibition of the menstrual cycle.
Collapse
|
214
|
Lee PA, Rogol A, Houk CP. Optimizing potential for fertility: fertility preservation considerations for the pediatric endocrinologist. Endocrinol Metab Clin North Am 2009; 38:761-75. [PMID: 19944291 DOI: 10.1016/j.ecl.2009.08.003] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
Abstract
Whether for the prepubertal or pubertal child, the goal of fertility preservation is to obtain cells or tissues to be used to produce future children. For the prepubertal child, preservation efforts involve germ cells, earlier forms of sperm, and immature follicles, rather than mature spermatozoa or follicles. Options for prepubertal children include for boys freezing testicular tissue and extracting testicular sperm or for girls obtaining ovarian cortical or follicular tissue for storage. These procedures involve extraction and storage of immature gametes for subsequent in vitro maturation, although attempts for sperm currently involve only animal studies. For adolescent subjects who have sufficient gonadal development and reserve, sperm, oocytes, and ovarian cortex can be retrieved as among adults.
Collapse
|
215
|
Franklin SL, Austin J, Reh CS, Ma NS, Kim M. 2009 Annual Meeting of the Endocrine Society Washington DC, United States (June 10-13, 2009)--selected highlights. PEDIATRIC ENDOCRINOLOGY REVIEWS : PER 2009; 7:50-58. [PMID: 20183933] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 05/28/2023]
|
216
|
Hyman SJ, Novoa Y, Holzman I. Perinatal endocrinology: common endocrine disorders in the sick and premature newborn. Endocrinol Metab Clin North Am 2009; 38:509-24. [PMID: 19717002 DOI: 10.1016/j.ecl.2009.06.005] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
Abstract
Endocrine disorders are common in infants in the neonatal ICU. They often are associated with prematurity, low birth weight or very low birth weight, and small size for gestational age. They also frequently occur in infants who are critically ill or stressed. This article describes the most common conditions and current knowledge regarding management.
Collapse
|
217
|
Domené HM, Longui CA, Guerra Junior G, Jasper HG, Lanes R. XX Annual Meeting of the Latin American Society for Pediatric Endocrinology (SLEP) Lima, Peru, October 11-14, 2008. PEDIATRIC ENDOCRINOLOGY REVIEWS : PER 2009; 7:48-53. [PMID: 20973255] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 05/30/2023]
|
218
|
Leroith D. Pediatric endocrinology: part I. Foreword. Endocrinol Metab Clin North Am 2009; 38:xi-xiii. [PMID: 19716998 DOI: 10.1016/j.ecl.2009.07.004] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
|
219
|
Abstract
This article reviews factors that contribute to excessive weight gain in children and outlines current knowledge regarding approaches for treating pediatric obesity. Most of the known genetic causes of obesity primarily increase energy intake. Genes regulating the leptin signaling pathway are particularly important for human energy homeostasis. Obesity is a chronic disorder that requires long-term strategies for management. The foundation for all treatments for pediatric obesity remains restriction of energy intake with lifestyle modification. There are few long-term studies of pharmacotherapeutic interventions for pediatric obesity. Bariatric surgical approaches are the most efficacious treatment but, because of their potential risks, are reserved for those with the most significant complications of obesity.
Collapse
|
220
|
Abstract
Patients with preoperative endocrinopathies represent a particular challenge not only to anesthesiologists but also to surgeons and perioperative clinicians. The "endocrine axis" is complex and has multiple feedback loops, some of which are endocrine and paracrine related, and others that are strongly influenced by the surgical stress response. Familiarity with several of the common endocrinopathies facilitates management in the perioperative period. This article focuses on 4 of the most common endocrinopathies: diabetes mellitus, hyperthyroidism, hypothyroidism, and adrenal insufficiency. Perioperative challenges in patients presenting with pheochromocytoma are also discussed.
Collapse
|
221
|
|
222
|
Pugeat M, Nicolino M. From paediatric to adult endocrinology care: the challenge of the transition period. PEDIATRIC ENDOCRINOLOGY REVIEWS : PER 2009; 6 Suppl 4:519-522. [PMID: 19550386] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 05/28/2023]
Abstract
Interest in the transition period when young people with chronic illness move from a paediatric service to an adult service has been driven by the increasing numbers of young patients making such a move. This brief article offers suggestions for successful transition programmes based on the recent personal experience of the authors, with a review of the available literature. We discuss how physicians need to adopt a flexible approach to the timing of the transfer, how an education programme is needed before the transition to allow patients to manage their illness independently, and how a co-ordinated approach between the paediatric and adult teams is of the utmost importance. The successful approach to transition will not only benefit the patient but, by linking the paediatric and adult services, may aid research into the long-term modalities for hormonal substitution, including thyroid, steroid and growth hormone deficiencies.
Collapse
|
223
|
Pearce SHS. Autoimmune disorders are among the most frequently encountered conditions in endocrine practice. Preface. Endocrinol Metab Clin North Am 2009; 38:xvii-xviii. [PMID: 19328409 DOI: 10.1016/j.ecl.2009.01.013] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/19/2022]
|
224
|
Resmini E, Minuto F, Colao A, Ferone D. Secondary diabetes associated with principal endocrinopathies: the impact of new treatment modalities. Acta Diabetol 2009; 46:85-95. [PMID: 19322513 DOI: 10.1007/s00592-009-0112-9] [Citation(s) in RCA: 87] [Impact Index Per Article: 5.8] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 01/19/2009] [Accepted: 02/23/2009] [Indexed: 12/26/2022]
Abstract
The secondary occurrence of type 2 diabetes with various hormonal diseases (e.g. pituitary, adrenal and/or thyroid diseases) is a recurrent observation. Indeed, impaired glucose tolerance (IGT) and overt diabetes mellitus are frequently associated with acromegaly and hypercortisolism (Cushing syndrome). The increased cardiovascular morbidity and mortality associated with acromegaly and Cushing syndrome may partly be a consequence of increased insulin resistance that normally accompanies hormone excess. Acromegalic patients are insulin resistant, both in the liver and in the periphery, displaying hyperinsulinemia and increased glucose turnover in the basal post-absorptive states. The prevalence of diabetes mellitus and that of IGT in acromegaly is reported to range 16-56%, whereas the degree of glucose tolerance seems correlated with circulating growth hormone (GH) levels, age, and disease duration. Moreover, a family history of diabetes and concomitant presence of arterial hypertension have been found to predispose to diabetes as well. GH has physiological effects on glucose metabolism, stimulating gluconeogenesis and lipolysis, which results in increased blood glucose and free fatty acid levels. Conversely, insulin-like growth factor 1 (IGF-I) enhances insulin sensitivity primarily on skeletal muscles. However, in acromegaly, increased IGF-I levels are unable to counteract the insulin-resistance status determined by GH excess. Therapy with somatostatin analogues (SSAs) induce control of GH and IGF-I excess in the majority of patients, but their inhibitory effect on pancreatic insulin secretion might complicate the overall effect of this treatment on glucose tolerance. Hypercortisolism produces visceral obesity, insulin resistance, and dyslipidemia that together with hypertension, hypercoagulability, and ventricular morphologic and functional abnormalities increase cardiovascular risk, and persist up to 5 years after resolution of hypercortisolism. Hypercortisolism leads to hyperglycaemia and reduced glucose tolerance, determines insulin resistance, stimulates hepatic gluconeogenesis and glicogenolisis. In Cushing syndrome the prevalence of diabetes varies between 20 and 50%, but probably this prevalence is underestimated, as not always an oral glucose tolerance test is performed in the presence of an apparently normal fasting glycaemia. Again, disease duration, rather than hormone levels, seems to be the major determinant in the occurrence of systemic complications in Cushing syndrome. Due to the impact they have on mortality and morbidity in both acromegaly and Cushing syndrome, these complications should be treated aggressively. In patients with neuroendocrine tumours (NETs) the occurrence of altered glucose tolerance may be due to a decreased insulin secretion, like it happens in patients who underwent pancreatic surgery and in those with pheochromocytoma, or to an altered counterbalance between hormones, such as in patients with glucagonoma and somatostatinoma. Moreover, SSAs represent a valid therapeutic choice in the symptomatic treatment of NETs, and also in this case the medical therapy of the primary disease, may have a significant impact on the prevalence of glucose metabolism imbalance. In thyroid disorders, an abnormal glucose tolerance may be principally encountered in hyperthyroidism. The pathogenesis is complex and scant data on prevalence and severity are found in the literature. Adequate treatment for glucose imbalance is mandatory in these peculiar patients in line with the American Diabetes Association and the European Association for the Study of Diabetes consensus statement. In particular, since traditional insulins have two features that may complicate therapy (absorption profiles, delayed onset of action and peak activity), the new insulin analogues could be of particular interest in the management of the secondary diabetes associated with endocrinopathies, considering the frailty of these patients. Indeed, it has been demonstrated that insulin glargine, given once daily, reduces the risk of hypoglycaemia compared with other formulations, and can facilitate a more aggressive insulin treatment in this class of patients.
Collapse
|
225
|
Francucci CM, Ghigo E, Boscaro M. Endocrinopathy-induced osteoporosis. Fourth National Meeting, Ancona, Italy, September 25-26, 2008. J Endocrinol Invest 2009; 32:1. [PMID: 19724157] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 04/19/2023]
|
226
|
Skałba P. [Progress in gynecological endocrinology]. Ginekol Pol 2008; 79:877-881. [PMID: 19175047] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 05/27/2023] Open
Abstract
The following paper attempted to present key articles on gynaecological endocrinology, published in the last three years. The aim of this study was not to describe and discuss complex and detailed endocrinological disorders. The author assumed readers possess appropriate knowledge about the presented issues. Thus, only the following topics have been presented: discoveries, new scientific conceptions and recently revised consensus and guidelines, which may be essential for practical application in gynaecological endocrinology. During the period of time under scrutiny, the pituitary-specific transcription factor-1 regulating the expression and differentiation of human growth hormone, prolactin and TSH, and the mechanism of the regulation of somatotrophs' apoptosis via Ret receptor have been discovered and defined. Furthermore, the fact that nuclear protein HMGA2 induces formation of pituitary tumours has also been discovered. The paper emphasizes the practical value of research on side effects of the cabergoline. The consensus on diagnosing polycystic ovary syndrome (PCOS) has been discussed, with emphasis on the role of hyperandrogenism as a necessary criterion to make a diagnosis. PCOS treatment with metformin and treatment of infertility in case of PCOS guidelines have been presented as well. In the last part of the paper, the care for peri- and postmenopausal women, especially the problems of systemic and local hormonal therapy, has been described. Polish Gynaecological Society Standards are stated as well.
Collapse
|
227
|
Proceedings of the International Conference on Neural Signaling: Opportunities for Novel Diagnostic Approaches and Therapies. February 16-20, 2008. Pacific Grove, California, USA. Ann N Y Acad Sci 2008; 1144:xi-264. [PMID: 19209418] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 05/27/2023]
|
228
|
Bays HE, González-Campoy JM, Henry RR, Bergman DA, Kitabchi AE, Schorr AB, Rodbard HW. Is adiposopathy (sick fat) an endocrine disease? Int J Clin Pract 2008; 62:1474-83. [PMID: 18681905 PMCID: PMC2658008 DOI: 10.1111/j.1742-1241.2008.01848.x] [Citation(s) in RCA: 57] [Impact Index Per Article: 3.6] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/13/2022] Open
Abstract
OBJECTIVE To review current consensus and controversy regarding whether obesity is a 'disease', examine the pathogenic potential of adipose tissue to promote metabolic disease and explore the merits of 'adiposopathy' and 'sick fat' as scientifically and clinically useful terms in defining when excessive body fat may represent a 'disease'. METHODS A group of clinicians and researchers, all with a background in endocrinology, assembled to evaluate the medical literature, as it pertains to the pathologic and pathogenic potential of adipose tissue, with an emphasis on metabolic diseases that are often promoted by excessive body weight. RESULTS The data support pathogenic adipose tissue as a disease. Challenges exist to convince many clinicians, patients, healthcare entities and the public that excessive body fat is often no less a 'disease' than the pathophysiological consequences related to anatomical abnormalities of other body tissues. 'Adiposopathy' has the potential to scientifically define adipose tissue anatomic and physiologic abnormalities, and their adverse consequences to patient health. Adiposopathy acknowledges that when positive caloric balance leads to adipocyte hypertrophy and visceral adiposity, then this may lead to pathogenic adipose tissue metabolic and immune responses that promote metabolic disease. From a patient perspective, explaining how excessive caloric intake might cause fat to become 'sick' also helps provide a rationale for patients to avoid weight gain. Adiposopathy also better justifies recommendations of weight loss as an effective therapeutic modality to improve metabolic disease in overweight and obese patients. CONCLUSION Adiposopathy (sick fat) is an endocrine disease.
Collapse
|
229
|
Abstract
CONTEXT The endocrine system is a common target in pathogenic autoimmune responses, and there has been recent progress in our understanding, diagnosis, and treatment of autoimmune endocrine diseases. SYNTHESIS Rapid progress has recently been made in our understanding of the genetic factors involved in endocrine autoimmune diseases. Studies on monogenic autoimmune diseases that include endocrine phenotypes like autoimmune polyglandular syndrome type 1 and immune dysregulation, polyendocrinopathy, enteropathy, X-linked have helped reveal the role of key regulators in the maintenance of immune tolerance. Highly powered genetic studies have found and confirmed many new genes outside of the established role of the human leukocyte antigen locus with these diseases, and indicate an essential role of immune response pathways in these diseases. Progress has also been made in identifying new autoantigens and the development of new animal models for the study of endocrine autoimmunity. Finally, although hormone replacement therapy is still likely to be a mainstay of treatment in these disorders, there are new agents being tested for potentially treating and reversing the underlying autoimmune process. CONCLUSION Although autoimmune endocrine disorders are complex in etiology, these recent advances should help contribute to improved outcomes for patients with, or at risk for, these disorders.
Collapse
|
230
|
Rohmer V, Dewailly D. [Editorial]. ANNALES D'ENDOCRINOLOGIE 2008; 69 Suppl 1:S1. [PMID: 18954852 DOI: 10.1016/s0003-4266(08)73960-x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/27/2023]
|
231
|
Asa SL, LiVolsi VA. New diagnostic and management approaches in endocrine pathology. Arch Pathol Lab Med 2008; 132:1228-30. [PMID: 18684021 DOI: 10.5858/2008-132-1228-ndamai] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 04/15/2008] [Indexed: 11/06/2022]
|
232
|
Crom DB. Metabolic abnormalities in an adult survivor of pediatric craniopharyngioma. ONCOLOGY (WILLISTON PARK, N.Y.) 2008; 22:43-46. [PMID: 19856572] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 05/28/2023]
|
233
|
Lewis CE, Yeh MW. Inherited endocrinopathies: an update. Mol Genet Metab 2008; 94:271-82. [PMID: 18434223 DOI: 10.1016/j.ymgme.2008.03.006] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 12/20/2007] [Revised: 03/10/2008] [Accepted: 03/10/2008] [Indexed: 12/15/2022]
Abstract
Inherited endocrinopathies, including multiple endocrine neoplasia type 1 (MEN-1), multiple endocrine neoplasia type 2 syndromes (MEN-2A, MEN-2B, familial medullary thyroid carcinoma), and inherited syndromes with pheochromocytoma (von Hippel-Lindau disease, neurofibromatosis type 1, others), comprise a heterogeneous group of cancer susceptibility syndromes that affect one or more components of the endocrine system. During the past several years, novel findings regarding genotype-phenotype correlation have highlighted the importance of establishing a genetic diagnosis in the treatment of these diseases. Here, we present a case-based review of recent advances in the genetics, diagnosis and management of inherited endocrinopathies.
Collapse
|
234
|
Domené HM, Jasper HG. The XIX Annual Meeting of the Latin American Society for Pediatric Endocrinology (SLEP) Mar del Plata October 13-17, 2007. PEDIATRIC ENDOCRINOLOGY REVIEWS : PER 2008; 5:915-921. [PMID: 18552755] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 05/26/2023]
|
235
|
Tanaka T, Yokoya S. The 41st Annual Meeting of the Japanese Society for Pediatric Endocrinology (JSPE), Yokohama, Japan, 7-9 November 2007. PEDIATRIC ENDOCRINOLOGY REVIEWS : PER 2008; 5:912-914. [PMID: 18552754] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 05/26/2023]
|
236
|
Ducarme G, Châtel P, Luton D. [Postpartum endocrine syndrome]. JOURNAL DE GYNECOLOGIE, OBSTETRIQUE ET BIOLOGIE DE LA REPRODUCTION 2008; 37:223-228. [PMID: 18314279 DOI: 10.1016/j.jgyn.2008.01.004] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 11/05/2007] [Revised: 01/09/2008] [Accepted: 01/16/2008] [Indexed: 05/26/2023]
Abstract
Postpartum endocrine syndromes occur in the year after delivery. They are due to immunologic and vascular modifications during pregnancy. The Sheehan syndrome is the first described postpartum endocrine syndrome and consists on a hypophyse necrosis in relation with a hypovolemic shock during delivery. The immunologic consequences of the pregnancy are the most frequent, sometimes discrete and transitory. The physiological evolution of the endocrine glands during pregnancy and the most frequent post-partum endocrine syndromes are discussed: postpartum lymphocytic hypophysitis, thyroiditis and Sheehan' syndrome.
Collapse
|
237
|
Geffner ME, Demay M, Raetzman L, Holm I, Diamanti-Kandarakis E, Savage MO, Francis G, Rogol AD. The 88th Annual Meeting of the Endocrine Society, June 24-27, 2006, Boston MA, USA: selected pediatric presentations. PEDIATRIC ENDOCRINOLOGY REVIEWS : PER 2008; 5:789-795. [PMID: 18368001] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 05/26/2023]
|
238
|
Numbenjapon N, Rapaport R, Monzavi R, Pitukcheewanont P, Ma N. 2007 Annual Meeting of the Endocrine Society Toronto, Canada (June 2-5, 2007): selected pediatric highlights. PEDIATRIC ENDOCRINOLOGY REVIEWS : PER 2008; 5:796-803. [PMID: 18368002] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 05/26/2023]
|
239
|
Zeng ZP. [Subclinical diseases: current situation and thoughts]. ZHONGHUA NEI KE ZA ZHI 2008; 47:177-179. [PMID: 18785495] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 05/26/2023]
|
240
|
Antonelli M, Azoulay E, Bonten M, Chastre J, Citerio G, Conti G, De Backer D, Lemaire F, Gerlach H, Groeneveld J, Hedenstierna G, Macrae D, Mancebo J, Maggiore SM, Mebazaa A, Metnitz P, Pugin J, Wernerman J, Zhang H. Year in review in Intensive Care Medicine, 2007. I. Experimental studies. Clinical studies: brain injury and neurology, renal failure and endocrinology. Intensive Care Med 2008; 34:229-42. [PMID: 18175106 PMCID: PMC2228383 DOI: 10.1007/s00134-007-0981-8] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/10/2007] [Accepted: 12/10/2007] [Indexed: 01/20/2023]
|
241
|
Sonino N, Ruini C, Navarrini C, Ottolini F, Sirri L, Paoletta A, Fallo F, Boscaro M, Fava GA. Psychosocial impairment in patients treated for pituitary disease: a controlled study. Clin Endocrinol (Oxf) 2007; 67:719-26. [PMID: 17608817 DOI: 10.1111/j.1365-2265.2007.02951.x] [Citation(s) in RCA: 28] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/19/2022]
Abstract
OBJECTIVE To verify whether patients with pituitary disorders in remission and on appropriate treatment display significant differences in psychological distress compared to healthy controls and other patients treated for nonpituitary endocrine disorders. DESIGN A single-centred, controlled study. PATIENTS Eighty-six outpatients cured or in remission for at least 9 months following appropriate treatment by surgery, irradiation and/or pharmacological interventions for pituitary disease were compared with 86 healthy subjects. A sample comprising 60 outpatients cured or in remission from nonpituitary endocrine disorders was also compared. MEASUREMENTS (1) A modified version of the Structural Clinical Interview for DSM-IV; (2) a shortened version of the structured interview for the Diagnostic Criteria for Psychosomatic Research (DCPR); (3) the Psychosocial Index (PSI); and (4) the Medical Outcomes Study (MOS) short form General Health Survey (SF-20) were employed. RESULTS Patients with pituitary disease displayed a higher prevalence of psychiatric disease (P < 0.001) compared to controls, but not when compared to nonpituitary endocrine patients. They also showed a higher prevalence of DCPR clusters compared to controls (P < 0.001), but not when compared to nonpituitary endocrine patients. At PSI and MOS (SF-20), patients with endocrine disease, whether pituitary or not, reported more psychological distress, and less well-being (P < 0.001) compared to controls. CONCLUSIONS At follow-up after appropriate treatment, we documented a high prevalence of psychopathology in patients with pituitary disease, which was however, similar to that found in nonpituitary endocrine patients. This is consistent with an increasing body of literature that reports difficulties in obtaining full recovery in patients treated for endocrine disorders.
Collapse
|
242
|
Hagiwara S. [Working despite having diseases: Endocrine and metabolic diseases]. RINSHO BYORI. THE JAPANESE JOURNAL OF CLINICAL PATHOLOGY 2007; Suppl 139:81-95. [PMID: 18062200] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 05/25/2023]
|
243
|
Peters CJ, Hindmarsh PC. Management of neonatal endocrinopathies--best practice guidelines. Early Hum Dev 2007; 83:553-61. [PMID: 17703902 DOI: 10.1016/j.earlhumdev.2007.05.001] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 05/16/2007] [Accepted: 05/21/2007] [Indexed: 01/11/2023]
Abstract
Neonatal emergencies are uncommon, but may lead to significant morbidity and mortality if not recognised and managed promptly. Disorders of sex development, hypoglycaemia, thyrotoxicosis and calcium balance are discussed, with emphasis on the clinical assessment, investigations and management of these disorders in the acute setting.
Collapse
|
244
|
Martinez A. XVIII Annual Meeting of the Sociedad Latinoamericana De Endocrinologia Pediatrica (SLEP). PEDIATRIC ENDOCRINOLOGY REVIEWS : PER 2007; 4:366-7. [PMID: 17643086] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 05/16/2023]
|
245
|
Abstract
Endocrine emergencies constitute only a small percentage of the emergency workload of general doctors, comprising about 1.5% of all hospital admission in England in 2004-5. Most of these are diabetes related with the remaining conditions totalling a few hundred cases at most. Hence any individual doctor might not have sufficient exposure to be confident in their management. This review discusses the management of diabetic ketoacidosis, hyperosmolar hyperglycaemic state, hypoglycaemia, hypercalcaemia, thyroid storm, myxoedema coma, acute adrenal insufficiency, phaeochromocytoma hypertensive crisis and pituitary apoplexy in the adult population.
Collapse
|
246
|
Proceedings of the 39th International Symposium on Growth Hormone and Growth Factors in Endocrinology and Metabolism, Berlin, Germany, May 11-12, 2007. HORMONE RESEARCH 2007; 68 Suppl 5:1-208. [PMID: 18354824] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 05/26/2023]
|
247
|
Growth hormone and growth factors in endocrinology and metabolism. Foreword. HORMONE RESEARCH 2007; 68 Suppl 5:1. [PMID: 18297763] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 05/25/2023]
|
248
|
Andrews P, Azoulay E, Antonelli M, Brochard L, Brun-Buisson C, De Backer D, Dobb G, Fagon JY, Gerlach H, Groeneveld J, Macrae D, Mancebo J, Metnitz P, Nava S, Pugin J, Pinsky M, Radermacher P, Richard C. Year in review in Intensive Care Medicine, 2006. I. Experimental studies. Clinical studies: brain injury, renal failure and endocrinology. Intensive Care Med 2006; 33:49-57. [PMID: 17180391 DOI: 10.1007/s00134-006-0501-2] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/29/2006] [Accepted: 11/29/2006] [Indexed: 12/31/2022]
|
249
|
Katikireddy CK, Kuschner WG. Critical care medicine update: essentials for the nonintensivist, part 2. ACTA ACUST UNITED AC 2006; 32:82-9. [PMID: 16845150 DOI: 10.1385/comp:32:2:82] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/06/2006] [Revised: 11/30/1999] [Accepted: 01/16/2006] [Indexed: 11/11/2022]
Abstract
In Part 2 of this update on the essentials of critical care medicine for the nonintensivist, we continue our review of common problems encountered in the intensive care unit (ICU). The focus of this part is on renal failure, acid-base disturbances, common ICU complications, nutrition management, endocrine disorders, prognostic indicators and principles of patient- and family-centered care.
Collapse
|
250
|
Fujikura J, Hosoda K, Iwakura H, Noguchi M, Nakao K. [Diabetes secondary to endocrinopathies]. NIHON RINSHO. JAPANESE JOURNAL OF CLINICAL MEDICINE 2006; Suppl 3:73-7. [PMID: 17022503] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 05/12/2023]
|